MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
Abstract RNA interference represents one of the most appealing therapeutic modalities for cancer because of its potency, versatility, and modularity. Because the mechanism is catalytic and affects the expression of disease-causing antigens at the post-transcriptional level, only small amounts of the...
Main Authors: | Byunghee Yoo, Alana Ross, Pamela Pantazopoulos, Zdravka Medarova |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-82528-2 |
Similar Items
-
In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor
by: Yoo, Byunghee, et al.
Published: (2016) -
Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
by: Mariane Le Fur, et al.
Published: (2021-07-01) -
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
by: Byunghee Yoo, et al.
Published: (2019-01-01) -
Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer
by: Akbar Ghorbani Alvanegh, et al.
Published: (2021-08-01) -
New Directions in the Study and Treatment of Metastatic Cancer
by: Byunghee Yoo, et al.
Published: (2018-07-01)